Logo Die Sachsen News

News for tumor

Cancer defeated, but the consequences remain: many brain tumor survivors still suffer from the long-term effects of radiotherapy years after their treatment. A research team at TU Dresden is now investigating these late effects – supported by more than two million euros in funding and with patients actively involved as research partners.

Sweet signals decoded: Biochemists track cell communication

How do cells talk to each other? A team at TU Dresden has succeeded in making the most important sensors on the cell surface visible for the first time. The so-called proteoglycans receive signals and control how cells grow and react. The new method could help to better understand cancer and develop new therapies in the future. | more

New marker shows which bladder cancer patients benefit from therapy

Researchers at the Helmholtz-Zentrum Dresden-Rossendorf have developed a molecular marker to help doctors choose the right bladder cancer therapy. The radiotracer NECT-224 makes visible whether tumors carry a certain protein to which modern drugs can dock. In summer 2025, it was used successfully for the first time on a patient at Dresden University Hospital. | more

Warum viele Führungskräfte an sich zweifeln – und was Führung wieder leicht macht

Coaching in Dresden begleitet bei Entscheidungen, beruflicher Neuorientierung, Konflikten, Überforderung und Lebensumbrüchen. Mit strukturierten Gesprächen und gezielten Fragen entstehen passende Lösungen, klare Prioritäten und mehr Selbstvertrauen. | more

How a protein keeps tumors alive and feeds them

A research group at TU Dresden has decoded a central mechanism in cancer cells. This enables safer therapies. | more

Dresden University Medicine expands interdisciplinary tumor patient care

Dresden University Medicine is expanding the care of tumor patients away from urban centers with the Mission4Sax pilot project. | more

Articles are loaded